Pharmacy Medical News about epilepsy; Lacosamide

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lacosamide: what can be expected from the next new antiepileptic drug
Epilepsy Currents, 09/09/09

Abou–Khalil BW – Results of this trial demonstrated the efficacy and tolerability of adjunctive lacosamide 200 and 400 mg/day and support that lacosamide may be an advantageous option for the treatment of partial–onset seizures in patients with epilepsy.

<< Previous
Tonabersat, a novel gap-junction modulator for the prevention of...

Next >>
The effects of pre-emptive analgesia with bupivacaine on acute...

Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09 Relevance Score: 91%

“It shouldn’t be something that's evil, it should be talked about”: A phenomenological approach to epilepsy and stigma
Seizure - European Journal of Epilepsy, 10/15/09 Relevance Score: 89%

Interictal EEG spikes identify the region of electrographic seizure onset in some, but not all, pediatric epilepsy patients
Epilepsia, 10/01/09 Relevance Score: 89%

Medically intractable epilepsy in Sturge-Weber syndrome is associated with cortical malformation: Implications for surgical therapy
Epilepsia, 10/01/09 Relevance Score: 89%

Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09 Relevance Score: 88%